Daniel Hennessy
Foot & Ankle Surgery · Denville, NJNPI 1477998946
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $691 and has fallen 88.6% since, to $79 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NJ, where the typical reported total is $1,926.
Across 58 payments — averaging $36.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$470
- Stryker$345
- Smith+Nephew$331
- Treace Medical Concepts, Inc.$215
- Integra Lifesciences Corporation$161
- Organogenesis Inc.$111
- plus $469 from 13 others
What the payments were for
- Food & beverage$2,102100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 8 | $470 |
| Stryker(2 entities) | 7 | $345 |
| Smith+Nephew | 13 | $331 |
| Treace Medical Concepts, Inc. | 3 | $215 |
| Integra Lifesciences Corporation | 5 | $161 |
| Organogenesis Inc. | 1 | $111 |
| Polarityte, Inc. | 5 | $98 |
| KCI USA, Inc. | 2 | $67 |
| Polynovo North America LLC | 1 | $44 |
| Orthofix Medical, Inc. | 1 | $43 |
| Merck | 3 | $37 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Reprise Biomedical, Inc. | 1 | $29 |
| Kerecis Limited | 1 | $26 |
| IBSA Pharma Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $18 |
| Solventum Corporation | 1 | $16 |
| In2bones USA, LLC | 1 | $15 |
| Paragon 28, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVOS$138
- Lapiplasty System$116
- PuraPly$111
- CITREFIX$104
How this compares
$2,102 in reported general payments places this provider in the 50th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 63 | $1,798 |
| Ammonium Lactate | 36 | $648 |
| Ketoconazole | 60 | $541 |
| Doxycycline Hyclate | 23 | $423 |
| Gabapentin | 18 | $178 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $165 |
| Mupirocin | 27 | $162 |
| Nystatin | 17 | $103 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Denville
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$843K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Mark SolomonCedar Knolls$232K
- Evan AdlerOld Bridge$195K
- Shane HollawellManasquan$169K
- Jacob ReinkrautRidgewood$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.